Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.08 trillion and total revenue of $109.96 billion.
Market Cap
1.08T
Revenue
109.96B
Profits
-42.31B
PE Ratio
n/a
Profit Margin
-38.47%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.31B | 2.06% | 369,909 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.45B | 1.33% | 147,095 | 14.34B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.14B | 5.59% | 340,652 | 3.71B |
| 4 | ARGX | argenx SE | 42.95B | 2.44% | 158,606 | 4.24B |
| 5 | INSM | Insmed Incorporated | 31.87B | 6.26% | 703,002 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 31.26B | 2.30% | 51,877 | 5.34B |
| 7 | BNTX | BioNTech SE | 22.32B | 2.32% | 211,814 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 21.21B | 4.60% | 1,717,950 | 1.94B |
| 9 | RPRX | Royalty Pharma plc | 19.88B | 1.84% | 640,726 | 2.38B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.81B | 3.01% | 1,025,702 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.11B | 0.94% | 1,100,083 | - |
| 12 | INCY | Incyte Corporation | 18.37B | 1.86% | 415,810 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.70B | 0.66% | 1,394,765 | 3.72B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.85B | 4.28% | 349,296 | 502.08M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.62B | 13.00% | 2,512,466 | - |
| 16 | ASND | Ascendis Pharma A/S | 13.59B | 2.72% | 109,065 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.09B | 4.99% | 1,117,856 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.62B | 1.99% | 345,069 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 11.12B | 3.03% | 664,205 | 2.32B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.71B | 4.87% | 92,941 | 958.40M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | 2.59% | 537,846 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.78B | 11.48% | 1,164,336 | 1.09B |
| 23 | ABVX | ABIVAX Société Anonyme | 8.70B | 0.54% | 462,662 | 5.37M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.69B | 5.90% | 129,783 | 7.46M |
| 25 | IBRX | ImmunityBio, Inc. | 8.42B | 10.45% | 18,209,813 | 113.29M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.27B | 1.86% | 129,759 | 638.50M |
| 27 | TECH | Bio-Techne Corporation | 8.21B | 0.06% | 578,640 | 1.22B |
| 28 | PCVX | Vaxcyte, Inc. | 8.18B | 3.97% | 654,124 | - |
| 29 | NUVL | Nuvalent, Inc. | 7.88B | 4.21% | 321,184 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 7.60B | 2.77% | 817,327 | 88.04M |
| 31 | KRYS | Krystal Biotech, Inc. | 7.45B | 3.16% | 98,075 | 389.13M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 7.45B | 1.76% | 252,680 | 1.40B |
| 33 | ACLX | Arcellx, Inc. | 6.70B | -0.16% | 408,497 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.60B | 8.67% | 260,257 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.60B | 3.03% | 323,938 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.12B | 3.07% | 57,435 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 5.99B | 5.52% | 722,989 | - |
| 38 | APGE | Apogee Therapeutics, Inc. | 5.75B | 13.29% | 1,809,482 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.70B | 1.08% | 476,095 | 189.76M |
| 40 | CGON | CG Oncology, Inc. | 5.60B | 3.90% | 226,420 | 4.04M |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.49B | 2.82% | 167,825 | 1.73B |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.47B | 3.15% | 145,613 | 521.31M |
| 43 | CAI | Caris Life Sciences, Inc. | 5.29B | -2.65% | 600,949 | 812.03M |
| 44 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | 3.86% | 703,017 | 7.50M |
| 45 | TGTX | TG Therapeutics, Inc. | 5.14B | 6.55% | 809,166 | 616.29M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.10B | 4.99% | 622,268 | - |
| 47 | IMVT | Immunovant, Inc. | 5.03B | 3.69% | 348,361 | - |
| 48 | CELC | Celcuity Inc. | 5.01B | 6.12% | 320,995 | - |
| 49 | ERAS | Erasca, Inc. | 4.77B | 4.70% | 2,194,494 | - |
| 50 | TERN | Terns Pharmaceuticals, Inc. | 4.75B | 5.50% | 63,236,067 | - |
| 51 | CORT | Corcept Therapeutics Incorporated | 4.60B | 27.94% | 7,004,451 | 761.41M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.58B | 2.74% | 379,600 | 3.51M |
| 53 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.07% | 613,641 | 634.21M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.16B | 3.35% | 37,391 | 268.09M |
| 55 | VKTX | Viking Therapeutics, Inc. | 3.86B | 3.92% | 775,392 | - |
| 56 | CNTA | Centessa Pharmaceuticals plc | 3.83B | 2.03% | 1,147,539 | 15.00M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.75B | 4.18% | 364,077 | 7.70M |
| 58 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | 4.82% | 924,859 | 1.07B |
| 59 | NAMS | NewAmsterdam Pharma Company N.V. | 3.64B | 5.26% | 213,008 | 22.50M |
| 60 | DNTH | Dianthus Therapeutics, Inc. | 3.59B | 2.79% | 372,021 | 2.04M |
| 61 | SYRE | Spyre Therapeutics, Inc. | 3.55B | 7.13% | 209,058 | - |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.46B | 5.39% | 345,982 | - |
| 63 | GPCR | Structure Therapeutics Inc. | 3.43B | 2.89% | 187,700 | - |
| 64 | DNLI | Denali Therapeutics Inc. | 3.40B | 2.34% | 2,613,083 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.27B | 3.34% | 372,580 | 1.03B |
| 66 | ALMS | Alumis Inc. | 3.13B | 6.63% | 522,695 | 24.05M |
| 67 | TNGX | Tango Therapeutics, Inc. | 3.10B | 11.60% | 1,467,046 | 62.38M |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.08B | 4.43% | 985,160 | - |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.02B | 1.71% | 62,343 | 803.79M |
| 70 | VERA | Vera Therapeutics, Inc. | 2.91B | 2.72% | 713,537 | - |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.90B | 4.38% | 285,378 | 70.85M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.90B | 2.77% | 357,483 | 588.99M |
| 73 | TARS | Tarsus Pharmaceuticals, Inc. | 2.84B | 5.70% | 97,352 | 451.36M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.83B | 4.58% | 262,251 | 376.07M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 2.75B | 2.49% | 282,547 | 218.71M |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.69B | 5.93% | 374,080 | 247.00M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.47B | 0.04% | 278,417 | 490.73M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.46B | 1.00% | 2,663,561 | 139.74M |
| 79 | SRPT | Sarepta Therapeutics, Inc. | 2.40B | 30.04% | 9,740,326 | 2.20B |
| 80 | IMNM | Immunome, Inc. | 2.40B | 5.00% | 595,823 | 6.94M |
| 81 | MANE | Veradermics, Incorporated | 2.40B | 1.20% | 157,342 | - |
| 82 | IRON | Disc Medicine, Inc. | 2.38B | 4.65% | 118,223 | - |
| 83 | ADMA | ADMA Biologics, Inc. | 2.36B | -12.53% | 14,934,032 | 510.17M |
| 84 | WVE | Wave Life Sciences Ltd. | 2.32B | 5.93% | 1,266,055 | 42.73M |
| 85 | APLS | Apellis Pharmaceuticals, Inc. | 2.28B | 3.48% | 555,069 | 1.00B |
| 86 | ORKA | Oruka Therapeutics, Inc. | 2.22B | 12.21% | 275,080 | - |
| 87 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.09% | 442,637 | 158.18M |
| 88 | ADPT | Adaptive Biotechnologies Corporation | 2.19B | 2.37% | 765,083 | 276.98M |
| 89 | SNDX | Syndax Pharmaceuticals, Inc. | 2.16B | 2.00% | 988,872 | 172.35M |
| 90 | NKTR | Nektar Therapeutics | 2.14B | 2.11% | 495,012 | 55.23M |
| 91 | AAPG | Ascentage Pharma Group International | 2.13B | - | 81 | 54.52M |
| 92 | CLDX | Celldex Therapeutics, Inc. | 2.11B | 1.67% | 126,591 | 1.55M |
| 93 | ELVN | Enliven Therapeutics, Inc. | 2.11B | 13.26% | 3,582,796 | - |
| 94 | TYRA | Tyra Biosciences, Inc. | 2.04B | 4.42% | 334,731 | - |
| 95 | MESO | Mesoblast Limited | 2.03B | 10.27% | 128,684 | 65.38M |
| 96 | STOK | Stoke Therapeutics, Inc. | 2.03B | 6.65% | 535,780 | 184.42M |
| 97 | GLPG | Galapagos NV | 2.02B | 3.09% | 258,286 | 1.31B |
| 98 | ZLAB | Zai Lab Limited | 2.01B | 4.04% | 289,183 | 460.16M |
| 99 | MLYS | Mineralys Therapeutics, Inc. | 2.01B | 6.64% | 393,907 | - |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.94B | 2.67% | 314,886 | 283.06M |
| 101 | ANAB | AnaptysBio, Inc. | 1.89B | 4.06% | 93,007 | 234.60M |
| 102 | DFTX | Definium Therapeutics, Inc. | 1.87B | 5.62% | 1,581,968 | - |
| 103 | RARE | Ultragenyx Pharmaceutical Inc. | 1.86B | 4.27% | 465,809 | 673.00M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 1.84B | 4.07% | 1,197,791 | 51.95M |
| 105 | ZYME | Zymeworks Inc. | 1.82B | 4.45% | 184,284 | 105.97M |
| 106 | RLAY | Relay Therapeutics, Inc. | 1.76B | 4.24% | 456,078 | 15.36M |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.75B | 5.26% | 266,829 | 54.03M |
| 108 | MAZE | Maze Therapeutics, Inc. | 1.73B | -29.03% | 5,332,207 | 2.50M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 3.46% | 293,986 | 11.13M |
| 110 | SLNO | Soleno Therapeutics, Inc. | 1.70B | 5.01% | 498,191 | 190.41M |
| 111 | SION | Sionna Therapeutics, Inc. | 1.69B | 8.08% | 89,915 | - |
| 112 | INVA | Innoviva, Inc. | 1.68B | 3.24% | 139,087 | 411.33M |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | -0.63% | 5,083,178 | 74.68M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.65B | 10.84% | 591,354 | 83.98M |
| 115 | VCEL | Vericel Corporation | 1.63B | -2.93% | 421,149 | 276.26M |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | 2.21% | 188,878 | 868.45M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.58B | 4.29% | 1,511,406 | 67.67M |
| 118 | IOVA | Iovance Biotherapeutics, Inc. | 1.57B | 5.52% | 5,455,944 | 263.50M |
| 119 | IMCR | Immunocore Holdings plc | 1.57B | 3.36% | 194,421 | 400.02M |
| 120 | GENB | Generate Biomedicines, Inc. | 1.57B | 2.33% | 86,044 | 31.89M |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.55B | 7.38% | 45,346 | - |
| 122 | NVAX | Novavax, Inc. | 1.53B | 1.67% | 1,112,394 | 1.12B |
| 123 | NUVB | Nuvation Bio Inc. | 1.53B | 3.04% | 988,512 | 62.90M |
| 124 | NBTX | Nanobiotix S.A. | 1.52B | 7.52% | 55,341 | 11.93M |
| 125 | OCS | Oculis Holding AG | 1.50B | 3.18% | 126,520 | 1.51M |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.49B | 9.21% | 463,333 | - |
| 127 | RAPP | Rapport Therapeutics, Inc. | 1.43B | 6.28% | 73,481 | - |
| 128 | PHVS | Pharvaris N.V. | 1.43B | 3.28% | 30,316 | - |
| 129 | PVLA | Palvella Therapeutics, Inc. | 1.42B | 2.93% | 100,174 | - |
| 130 | ARDX | Ardelyx, Inc. | 1.40B | 6.36% | 1,253,330 | 407.32M |
| 131 | MBX | MBX Biosciences, Inc. | 1.38B | 4.74% | 104,298 | - |
| 132 | ATAI | AtaiBeckley Inc. | 1.32B | 7.69% | 1,600,786 | 4.09M |
| 133 | IMTX | Immatics N.V. | 1.32B | 7.07% | 157,856 | 56.67M |
| 134 | BHVN | Biohaven Ltd. | 1.30B | 2.86% | 605,465 | - |
| 135 | VIR | Vir Biotechnology, Inc. | 1.29B | 8.28% | 1,098,509 | 68.56M |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | 8.84% | 1,035,781 | 9.77M |
| 137 | ZBIO | Zenas BioPharma, Inc. | 1.28B | 6.17% | 140,640 | 10.00M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.28B | 8.49% | 496,835 | 123.67M |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.28B | 6.46% | 268,409 | - |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.25B | 2.73% | 362,493 | - |
| 141 | KOD | Kodiak Sciences Inc. | 1.23B | 5.72% | 203,798 | - |
| 142 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | 8.33% | 552,923 | - |
| 143 | ORIC | ORIC Pharmaceuticals, Inc. | 1.18B | 5.59% | 489,331 | - |
| 144 | PHAR | Pharming Group N.V. | 1.12B | 2.44% | 7,493 | 376.13M |
| 145 | EYPT | EyePoint, Inc. | 1.11B | 5.56% | 243,643 | 31.37M |
| 146 | SEPN | Septerna, Inc. | 1.10B | 4.65% | 38,312 | 45.95M |
| 147 | PGEN | Precigen, Inc. | 1.10B | -0.64% | 1,514,693 | 6.31M |
| 148 | SVRA | Savara Inc. | 1.09B | 5.85% | 443,779 | - |
| 149 | TVGN | Tevogen Bio Holdings Inc. | 1.05B | -0.19% | 10,431 | - |
| 150 | ABCL | AbCellera Biologics Inc. | 1.04B | 3.93% | 774,010 | 75.13M |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.04B | 4.35% | 149,740 | - |
| 152 | AVBP | ArriVent BioPharma, Inc. | 1.01B | 3.78% | 71,774 | - |
| 153 | GERN | Geron Corporation | 999.25M | 3.31% | 4,540,621 | 183.88M |
| 154 | CMPX | Compass Therapeutics, Inc. | 995.89M | 3.75% | 396,710 | 850.00K |
| 155 | QURE | uniQure N.V. | 987.96M | 4.08% | 414,543 | 16.10M |
| 156 | AKTS | Aktis Oncology, Inc. | 986.89M | 0.86% | 90,993 | 5.56M |
| 157 | INBX | Inhibrx Biosciences, Inc. | 981.30M | 6.43% | 54,633 | 1.30M |
| 158 | SLS | SELLAS Life Sciences Group, Inc. | 971.54M | 8.31% | 3,029,270 | - |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | 936.30M | 2.65% | 733,308 | 291.85M |
| 160 | XNCR | Xencor, Inc. | 931.40M | 6.81% | 211,259 | 125.58M |
| 161 | ABUS | Arbutus Biopharma Corporation | 891.38M | 5.80% | 920,901 | 14.08M |
| 162 | URGN | UroGen Pharma Ltd. | 883.10M | 2.72% | 102,166 | 109.79M |
| 163 | FTRE | Fortrea Holdings Inc. | 871.42M | -2.71% | 211,567 | 2.72B |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 871.27M | 5.54% | 447,179 | - |
| 165 | GHRS | GH Research PLC | 870.89M | 4.85% | 28,726 | - |
| 166 | IVA | Inventiva S.A. | 854.39M | 1.99% | 76,802 | 19.93M |
| 167 | JANX | Janux Therapeutics, Inc. | 854.08M | 3.54% | 690,624 | 10.00M |
| 168 | SGP | SpyGlass Pharma, Inc. | 848.26M | 7.25% | 27,061 | - |
| 169 | KALV | KalVista Pharmaceuticals, Inc. | 847.16M | 1.82% | 618,183 | 1.43M |
| 170 | ANL | Adlai Nortye Ltd. | 833.58M | 7.73% | 57,083 | -1.35M |
| 171 | EVMN | Evommune, Inc. | 832.74M | 9.99% | 141,604 | 13.00M |
| 172 | SANA | Sana Biotechnology, Inc. | 831.29M | 6.68% | 1,673,680 | - |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 818.72M | 3.28% | 219,122 | 175.11M |
| 174 | SPRY | ARS Pharmaceuticals, Inc. | 792.39M | 5.84% | 498,122 | 84.28M |
| 175 | TBPH | Theravance Biopharma, Inc. | 782.69M | 2.01% | 147,093 | 107.46M |
| 176 | MPLT | MapLight Therapeutics, Inc. | 774.20M | 4.48% | 23,403 | - |
| 177 | CTMX | CytomX Therapeutics, Inc. | 759.03M | 5.19% | 1,258,170 | 76.20M |
| 178 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 748.31M | 7.22% | 35,910 | - |
| 179 | KURA | Kura Oncology, Inc. | 745.50M | 4.58% | 328,639 | 67.48M |
| 180 | OMER | Omeros Corporation | 743.75M | 3.05% | 247,112 | - |
| 181 | MNKD | MannKind Corporation | 727.12M | 3.06% | 1,477,617 | 348.97M |
| 182 | LXRX | Lexicon Pharmaceuticals, Inc. | 713.90M | -2.03% | 1,562,999 | 49.80M |
| 183 | SLDB | Solid Biosciences Inc. | 711.37M | 8.23% | 270,614 | - |
| 184 | GYRE | Gyre Therapeutics, Inc. | 705.90M | 4.90% | 48,820 | 116.59M |
| 185 | DRUG | Bright Minds Biosciences Inc. | 703.37M | 5.60% | 57,334 | - |
| 186 | ARVN | Arvinas, Inc. | 700.37M | 6.41% | 178,453 | 262.60M |
| 187 | JBIO | Jade Biosciences, Inc. | 690.43M | 5.58% | 165,655 | - |
| 188 | OCGN | Ocugen, Inc. | 685.31M | 8.85% | 5,927,078 | 4.41M |
| 189 | RLMD | Relmada Therapeutics, Inc. | 682.84M | 6.72% | 928,360 | - |
| 190 | PRME | Prime Medicine, Inc. | 669.85M | 5.40% | 845,286 | 4.63M |
| 191 | ANRO | Alto Neuroscience, Inc. | 669.26M | 3.76% | 62,766 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 664.21M | 4.46% | 150,476 | - |
| 193 | ANNX | Annexon, Inc. | 642.43M | 7.40% | 965,185 | - |
| 194 | EIKN | Eikon Therapeutics, Inc. | 633.78M | 6.15% | 348,398 | - |
| 195 | MGTX | MeiraGTx Holdings plc | 623.00M | 4.45% | 152,229 | 27.42M |
| 196 | DRTS | Alpha Tau Medical Ltd. | 619.59M | 0.43% | 72,909 | - |
| 197 | LBRX | LB Pharmaceuticals Inc | 616.03M | 4.19% | 53,379 | - |
| 198 | MDXG | MiMedx Group, Inc. | 610.61M | -0.48% | 146,253 | 418.63M |
| 199 | AGMB | AgomAb Therapeutics NV | 609.21M | 7.34% | 64,386 | - |
| 200 | TECX | Tectonic Therapeutic, Inc. | 594.47M | 5.29% | 85,709 | - |
| 201 | REPL | Replimune Group, Inc. | 589.16M | 2.37% | 676,875 | - |
| 202 | VALN | Valneva SE | 564.47M | 1.40% | 315,446 | 205.07M |
| 203 | ALLO | Allogene Therapeutics, Inc. | 563.13M | 4.52% | 1,653,725 | 22.00K |
| 204 | YDES | YD Bio Limited | 560.80M | 3.17% | 13,957 | 510.36K |
| 205 | DBVT | DBV Technologies S.A. | 552.65M | 3.27% | 163,841 | 5.50M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 546.02M | 1.64% | 237,367 | 106.47M |
| 207 | ZURA | Zura Bio Limited | 527.54M | 3.35% | 167,035 | - |
| 208 | CRMD | CorMedix Inc. | 526.48M | 3.10% | 354,223 | 311.71M |
| 209 | NAUT | Nautilus Biotechnology, Inc. | 514.06M | 3.04% | 630,527 | - |
| 210 | UPB | Upstream Bio, Inc. | 511.21M | 11.95% | 254,488 | 2.80M |
| 211 | FDMT | 4D Molecular Therapeutics, Inc. | 508.47M | 8.50% | 348,804 | 85.21M |
| 212 | ADCT | ADC Therapeutics SA | 508.18M | 1.52% | 157,747 | 81.36M |
| 213 | CTNM | Contineum Therapeutics, Inc. | 504.78M | 9.65% | 41,890 | - |
| 214 | RCKT | Rocket Pharmaceuticals, Inc. | 499.42M | 7.73% | 1,679,684 | - |
| 215 | PRTA | Prothena Corporation plc | 489.88M | 4.24% | 172,841 | 9.68M |
| 216 | LRMR | Larimar Therapeutics, Inc. | 489.29M | 3.06% | 3,337,159 | - |
| 217 | RIGL | Rigel Pharmaceuticals, Inc. | 487.14M | 0.92% | 71,030 | 294.28M |
| 218 | LYEL | Lyell Immunopharma, Inc. | 485.25M | 5.69% | 20,932 | 36.00K |
| 219 | ENGN | enGene Holdings Inc. | 478.97M | 3.62% | 41,213 | - |
| 220 | FULC | Fulcrum Therapeutics, Inc. | 471.53M | 5.67% | 148,811 | 80.00M |
| 221 | TRDA | Entrada Therapeutics, Inc. | 468.22M | 6.63% | 36,455 | 25.42M |
| 222 | ASMB | Assembly Biosciences, Inc. | 462.72M | 3.33% | 19,430 | 72.30M |
| 223 | MRVI | Maravai LifeSciences Holdings, Inc. | 456.72M | 1.30% | 645,165 | 185.74M |
| 224 | STTK | Shattuck Labs, Inc. | 450.14M | 2.78% | 266,792 | 1.00M |
| 225 | ABSI | Absci Corporation | 449.12M | -2.49% | 4,684,703 | 2.80M |
| 226 | VSTM | Verastem, Inc. | 447.96M | 3.45% | 1,225,599 | 30.91M |
| 227 | DNA | Ginkgo Bioworks Holdings, Inc. | 444.29M | 5.16% | 398,618 | 170.16M |
| 228 | ALT | Altimmune, Inc. | 438.34M | 4.01% | 738,417 | 41.00K |
| 229 | IVVD | Invivyd, Inc. | 438.02M | 8.39% | 911,286 | 53.43M |
| 230 | ACRS | Aclaris Therapeutics, Inc. | 432.94M | 8.79% | 757,044 | 7.83M |
| 231 | AVIR | Atea Pharmaceuticals, Inc. | 431.03M | 1.50% | 135,815 | - |
| 232 | RGNX | REGENXBIO Inc. | 428.39M | 6.27% | 401,127 | 170.44M |
| 233 | LXEO | Lexeo Therapeutics, Inc. | 424.79M | 5.82% | 284,266 | - |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.55M | 7.11% | 89,718 | - |
| 235 | VNDA | Vanda Pharmaceuticals Inc. | 422.03M | 4.69% | 451,826 | 216.11M |
| 236 | NMRA | Neumora Therapeutics, Inc. | 421.90M | 2.23% | 335,690 | - |
| 237 | AURA | Aura Biosciences, Inc. | 419.44M | 4.68% | 83,524 | - |
| 238 | IPSC | Century Therapeutics, Inc. | 406.17M | 0.89% | 387,223 | 109.16M |
| 239 | STRO | Sutro Biopharma, Inc. | 405.07M | 3.73% | 302,741 | 102.48M |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 396.05M | 7.43% | 988,829 | 14.56M |
| 241 | PRTC | PureTech Health plc | 382.24M | 1.11% | 264 | 6.39M |
| 242 | MNPR | Monopar Therapeutics Inc. | 381.91M | 3.44% | 124,803 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 376.01M | 2.29% | 26,658 | - |
| 244 | CADL | Candel Therapeutics, Inc. | 372.09M | 5.61% | 676,875 | - |
| 245 | GLSI | Greenwich LifeSciences, Inc. | 369.64M | 3.89% | 81,200 | - |
| 246 | NAGE | Niagen Bioscience, Inc. | 368.37M | 1.32% | 182,603 | 129.42M |
| 247 | XFOR | X4 Pharmaceuticals, Inc. | 368.22M | 6.02% | 166,441 | 35.11M |
| 248 | XOMA | XOMA Royalty Corporation | 366.69M | 5.41% | 35,745 | 52.15M |
| 249 | DMAC | DiaMedica Therapeutics Inc. | 365.06M | 1.74% | 57,485 | - |
| 250 | AUTL | Autolus Therapeutics plc | 363.29M | 3.41% | 1,625,915 | 51.13M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 359.98M | 2.69% | 43,658 | 66.98M |
| 252 | NGNE | Neurogene Inc. | 358.21M | 10.05% | 63,704 | 925.00K |
| 253 | KYTX | Kyverna Therapeutics, Inc. | 348.62M | 4.19% | 294,746 | - |
| 254 | PALI | Palisade Bio, Inc. | 348.36M | 5.00% | 2,864,806 | - |
| 255 | PEPG | PepGen Inc. | 348.00M | 6.67% | 178,788 | - |
| 256 | IMRX | Immuneering Corporation | 347.83M | 2.87% | 265,811 | - |
| 257 | ARMP | Armata Pharmaceuticals, Inc. | 337.50M | 13.15% | 19,294 | 5.05M |
| 258 | IRD | Opus Genetics, Inc. | 334.40M | 4.21% | 164,618 | 14.20M |
| 259 | PBYI | Puma Biotechnology, Inc. | 331.71M | 4.15% | 96,016 | 228.37M |
| 260 | BCYC | Bicycle Therapeutics plc | 327.62M | 4.44% | 257,367 | 72.59M |
| 261 | CLYM | Climb Bio, Inc. | 327.21M | 2.54% | 271,329 | - |
| 262 | AVTX | Avalo Therapeutics, Inc. | 326.79M | 6.62% | 314,739 | 59.00K |
| 263 | FBRX | Forte Biosciences, Inc. | 323.82M | 0.51% | 191,215 | - |
| 264 | CBIO | Crescent Biopharma, Inc. | 323.24M | 12.36% | 143,678 | 10.84M |
| 265 | NBP | NovaBridge Biosciences | 318.20M | 9.52% | 444,265 | - |
| 266 | OVID | Ovid Therapeutics Inc. | 317.16M | -0.62% | 866,627 | 7.25M |
| 267 | CABA | Cabaletta Bio, Inc. | 316.71M | 6.55% | 876,459 | - |
| 268 | IMMX | Immix Biopharma, Inc. | 310.60M | 7.93% | 419,137 | - |
| 269 | PLYX | Polaryx Therapeutics, Inc. | 310.10M | 1.71% | 118,776 | - |
| 270 | SRZN | Surrozen, Inc. | 308.99M | 7.60% | 23,150 | 3.48M |
| 271 | ACIU | AC Immune SA | 298.75M | 2.64% | 87,225 | 4.51M |
| 272 | RZLT | Rezolute, Inc. | 295.23M | 14.68% | 7,910,587 | - |
| 273 | FHTX | Foghorn Therapeutics Inc. | 294.68M | 4.58% | 56,677 | 30.91M |
| 274 | TARA | Protara Therapeutics, Inc. | 292.60M | 7.98% | 195,856 | - |
| 275 | LENZ | LENZ Therapeutics, Inc. | 285.48M | 0.83% | 519,750 | 19.09M |
| 276 | ENLV | Enlivex Ltd. | 280.11M | 7.27% | 10,727,567 | - |
| 277 | NERV | Minerva Neurosciences, Inc. | 277.82M | 6.29% | 75,875 | - |
| 278 | OBIO | Orchestra BioMed Holdings, Inc. | 275.05M | 0.86% | 106,159 | 33.48M |
| 279 | CHRS | Coherus Oncology, Inc. | 272.05M | 6.14% | 580,801 | 42.17M |
| 280 | ALXO | ALX Oncology Holdings Inc. | 270.89M | 0.90% | 993,926 | - |
| 281 | PROK | ProKidney Corp. | 264.01M | 3.91% | 280,931 | 893.00K |
| 282 | AVXL | Anavex Life Sciences Corp. | 263.19M | -32.22% | 8,964,376 | - |
| 283 | CCCC | C4 Therapeutics, Inc. | 262.00M | 7.40% | 693,876 | 35.95M |
| 284 | SLN | Silence Therapeutics plc | 256.01M | 4.23% | 219,703 | 559.00K |
| 285 | ABEO | Abeona Therapeutics Inc. | 254.44M | 3.00% | 363,781 | 5.82M |
| 286 | CNTX | Context Therapeutics Inc. | 252.67M | -13.52% | 838,990 | - |
| 287 | VYGR | Voyager Therapeutics, Inc. | 247.93M | 6.12% | 218,458 | 40.37M |
| 288 | OABI | OmniAb, Inc. | 245.41M | 1.50% | 66,929 | 18.67M |
| 289 | ALEC | Alector, Inc. | 242.25M | 5.53% | 227,957 | 21.05M |
| 290 | CLLS | Cellectis S.A. | 241.41M | 2.63% | 16,443 | 79.59M |
| 291 | CAMP | Camp4 Therapeutics Corporation | 239.87M | 1.99% | 32,015 | 3.50M |
| 292 | TENX | Tenax Therapeutics, Inc. | 237.67M | 4.46% | 118,816 | - |
| 293 | HELP | Cybin Inc. | 237.67M | 5.32% | 293,331 | - |
| 294 | EDIT | Editas Medicine, Inc. | 230.00M | 4.44% | 336,090 | 40.52M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 227.02M | 1.84% | 19,717 | 19.39M |
| 296 | KROS | Keros Therapeutics, Inc. | 221.13M | 2.05% | 80,934 | 244.06M |
| 297 | ELDN | Eledon Pharmaceuticals, Inc. | 220.73M | 0.69% | 404,012 | - |
| 298 | MDWD | MediWound Ltd. | 219.61M | 3.01% | 19,210 | 16.96M |
| 299 | NVCT | Nuvectis Pharma, Inc. | 215.77M | 2.45% | 13,157 | - |
| 300 | TNXP | Tonix Pharmaceuticals Holding Corp. | 210.46M | 2.35% | 174,413 | 13.11M |
| 301 | PRLD | Prelude Therapeutics Incorporated | 206.02M | 4.81% | 38,192 | 12.14M |
| 302 | ELTX | Elicio Therapeutics, Inc. | 203.46M | 4.83% | 41,704 | - |
| 303 | CGEN | Compugen Ltd. | 201.87M | 3.14% | 46,738 | 72.76M |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 201.80M | 6.77% | 191,061 | 82.03M |
| 305 | SABS | SAB Biotherapeutics, Inc. | 195.65M | -0.78% | 253,750 | 114.70K |
| 306 | GALT | Galectin Therapeutics Inc. | 193.42M | 6.01% | 80,831 | - |
| 307 | MGNX | MacroGenics, Inc. | 193.21M | 11.36% | 687,670 | 149.50M |
| 308 | CBUS | Cibus, Inc. | 189.94M | 1.29% | 91,495 | 3.64M |
| 309 | ADAG | Adagene Inc. | 188.53M | 10.80% | 47,331 | 103.20K |
| 310 | ZNTL | Zentalis Pharmaceuticals, Inc. | 188.21M | 5.47% | 132,597 | 26.87M |
| 311 | CRBU | Caribou Biosciences, Inc. | 185.54M | 5.49% | 403,758 | 11.16M |
| 312 | FENC | Fennec Pharmaceuticals Inc. | 181.35M | 7.14% | 146,076 | 44.64M |
| 313 | CNTB | Connect Biopharma Holdings Limited | 180.55M | 3.19% | 180,509 | 762.00K |
| 314 | NTHI | NeOnc Technologies Holdings, Inc. | 177.79M | 4.05% | 9,546 | 59.99K |
| 315 | PLX | Protalix BioTherapeutics, Inc. | 173.31M | 4.11% | 483,097 | 52.74M |
| 316 | CNTN | Canton Strategic Holdings, Inc. | 173.10M | 3.38% | 298,377 | - |
| 317 | IMUX | Immunic, Inc. | 172.21M | 5.60% | 1,185,559 | - |
| 318 | WHWK | Whitehawk Therapeutics, Inc. | 170.14M | 0.42% | 41,956 | 7.15M |
| 319 | PRQR | ProQR Therapeutics N.V. | 166.47M | 6.04% | 121,315 | 19.19M |
| 320 | RNAC | Cartesian Therapeutics, Inc. | 165.42M | 2.80% | 64,550 | 2.80M |
| 321 | ABOS | Acumen Pharmaceuticals, Inc. | 165.37M | 5.41% | 202,465 | - |
| 322 | TNYA | Tenaya Therapeutics, Inc. | 163.70M | -0.40% | 1,920,571 | - |
| 323 | CDXS | Codexis, Inc. | 160.84M | 5.99% | 510,559 | 70.39M |
| 324 | DTIL | Precision BioSciences, Inc. | 160.72M | 1.56% | 86,952 | 34.26M |
| 325 | MOLN | Molecular Partners AG | 159.45M | -2.02% | 695 | 856.30K |
| 326 | KRRO | Korro Bio, Inc. | 159.30M | 4.40% | 105,015 | 6.39M |
| 327 | HUMA | Humacyte, Inc. | 157.72M | 6.02% | 3,538,408 | 1.57M |
| 328 | EVAX | Evaxion A/S | 154.71M | 0.95% | 7,784 | 7.53M |
| 329 | SGMT | Sagimet Biosciences Inc. | 154.13M | 2.16% | 146,631 | - |
| 330 | NKTX | Nkarta, Inc. | 153.42M | 5.37% | 180,319 | - |
| 331 | ACHV | Achieve Life Sciences, Inc. | 153.33M | -0.69% | 1,044,112 | - |
| 332 | VTVT | vTv Therapeutics Inc. | 151.64M | 6.32% | 58,202 | 17.00K |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 150.86M | 6.03% | 795,760 | 1.55M |
| 334 | PMN | ProMIS Neurosciences, Inc. | 150.70M | -3.59% | 14,098 | - |
| 335 | HRTX | Heron Therapeutics, Inc. | 147.06M | 2.03% | 658,686 | 154.90M |
| 336 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 146.41M | 0.92% | 98,351 | - |
| 337 | KLRS | Kalaris Therapeutics, Inc. | 144.45M | 1.61% | 37,043 | - |
| 338 | FATE | Fate Therapeutics, Inc. | 144.17M | 9.73% | 741,594 | 6.65M |
| 339 | UNCY | Unicycive Therapeutics, Inc. | 142.92M | 4.07% | 238,264 | - |
| 340 | MENS | Jyong Biotech Ltd. | 142.53M | -4.00% | 86,646 | - |
| 341 | ANTX | AN2 Therapeutics, Inc. | 141.25M | 4.24% | 366,451 | - |
| 342 | AGEN | Agenus Inc. | 138.62M | 1.40% | 174,759 | 114.20M |
| 343 | ORMP | Oramed Pharmaceuticals Inc. | 138.11M | 1.46% | 55,398 | 2.00M |
| 344 | SPRO | Spero Therapeutics, Inc. | 136.90M | 2.53% | 87,473 | 40.55M |
| 345 | VOR | Vor Biopharma Inc. | 135.34M | 7.00% | 303,944 | - |
| 346 | ARTV | Artiva Biotherapeutics, Inc. | 134.46M | 4.02% | 23,962 | 251.00K |
| 347 | BDTX | Black Diamond Therapeutics, Inc. | 127.75M | 4.21% | 210,369 | 70.00M |
| 348 | IKT | Inhibikase Therapeutics, Inc. | 125.54M | 4.37% | 300,379 | 1.00 |
| 349 | SGMO | Sangamo Therapeutics, Inc. | 123.19M | 4.15% | 4,823,878 | 32.88M |
| 350 | EQ | Equillium, Inc. | 121.79M | 2.56% | 55,544 | 4.39M |
| 351 | IPHA | Innate Pharma S.A. | 120.90M | 2.38% | 636 | 14.84M |
| 352 | CRDF | Cardiff Oncology, Inc. | 119.98M | 1.45% | 187,006 | 593.00K |
| 353 | ACOG | Alpha Cognition Inc. | 117.95M | -2.95% | 14,680 | 7.43M |
| 354 | GNLX | Genelux Corporation | 115.15M | 6.20% | 88,246 | 8.00K |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 109.86M | 1.27% | 144,408 | 65.34K |
| 356 | RANI | Rani Therapeutics Holdings, Inc. | 109.73M | 6.13% | 322,102 | 1.20M |
| 357 | ALDX | Aldeyra Therapeutics, Inc. | 108.93M | -3.21% | 2,112,798 | - |
| 358 | QTTB | Q32 Bio Inc. | 105.62M | -1.10% | 160,929 | 53.74M |
| 359 | SPRB | Spruce Biosciences, Inc. | 102.90M | 16.53% | 66,871 | 697.00K |
| 360 | COYA | Coya Therapeutics, Inc. | 102.04M | 4.82% | 89,526 | 7.95M |
| 361 | ONCY | Oncolytics Biotech Inc. | 101.44M | 2.08% | 273,459 | - |
| 362 | HURA | TuHURA Biosciences, Inc. | 99.44M | -1.52% | 141,529 | - |
| 363 | SEER | Seer, Inc. | 99.30M | 3.53% | 82,710 | 16.58M |
| 364 | TTRX | Turn Therapeutics Inc. | 99.23M | 2.69% | 315 | - |
| 365 | CGTX | Cognition Therapeutics, Inc. | 98.87M | 1.82% | 605,338 | - |
| 366 | KPTI | Karyopharm Therapeutics Inc. | 96.67M | -3.13% | 860,238 | 146.07M |
| 367 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 95.27M | -1.41% | 284,113 | - |
| 368 | ANIX | Anixa Biosciences, Inc. | 90.86M | 4.63% | 66,213 | - |
| 369 | MAIA | MAIA Biotechnology, Inc. | 90.40M | 3.47% | 165,040 | - |
| 370 | FBIO | Fortress Biotech, Inc. | 90.32M | -0.34% | 244,479 | 62.30M |
| 371 | PYXS | Pyxis Oncology, Inc. | 89.85M | 5.15% | 87,151 | 13.86M |
| 372 | BMEA | Biomea Fusion, Inc. | 88.93M | 8.85% | 1,350,563 | - |
| 373 | MCRB | Seres Therapeutics, Inc. | 88.29M | 11.23% | 22,829 | 789.00K |
| 374 | GOSS | Gossamer Bio, Inc. | 84.82M | 4.78% | 7,431,120 | 48.47M |
| 375 | NRXS | NeurAxis, Inc. | 82.96M | 5.18% | 71,014 | 3.57M |
| 376 | VANI | Vivani Medical, Inc. | 82.44M | 0.89% | 38,090 | - |
| 377 | PLRX | Pliant Therapeutics, Inc. | 82.35M | 3.91% | 179,078 | - |
| 378 | CSBR | Champions Oncology, Inc. | 81.78M | -0.17% | 310 | 57.95M |
| 379 | AARD | Aardvark Therapeutics, Inc. | 81.16M | -1.33% | 99,955 | - |
| 380 | KZIA | Kazia Therapeutics Limited | 80.31M | 3.37% | 18,675 | 1.27M |
| 381 | ATYR | aTyr Pharma, Inc. | 80.03M | 3.37% | 343,467 | 190.00K |
| 382 | NRXP | NRx Pharmaceuticals, Inc. | 80.02M | 13.62% | 1,167,769 | 1.23M |
| 383 | PYPD | PolyPid Ltd. | 79.19M | 6.62% | 52,423 | - |
| 384 | VRCA | Verrica Pharmaceuticals Inc. | 78.34M | 1.79% | 21,374 | 35.58M |
| 385 | DWTX | Dogwood Therapeutics, Inc. | 78.16M | -9.65% | 75,520 | - |
| 386 | GUTS | Fractyl Health, Inc. | 74.44M | 9.01% | 5,214,044 | 3.00K |
| 387 | PMVP | PMV Pharmaceuticals, Inc. | 74.13M | - | 97,443 | - |
| 388 | IBIO | iBio, Inc. | 74.10M | 3.12% | 351,774 | 300.00K |
| 389 | CING | Cingulate Inc. | 73.73M | -5.51% | 239,031 | - |
| 390 | GRCE | Grace Therapeutics, Inc. | 73.68M | 7.25% | 412,378 | - |
| 391 | XBIT | XBiotech Inc. | 72.26M | 0.64% | 20,019 | - |
| 392 | MNOV | MediciNova, Inc. | 71.37M | - | 14,140 | 409.66K |
| 393 | PTHS | Pelthos Therapeutics Inc. | 70.87M | -4.00% | 1,380 | 16.80M |
| 394 | GANX | Gain Therapeutics, Inc. | 70.75M | 5.38% | 183,832 | - |
| 395 | IFRX | InflaRx N.V. | 69.78M | -5.36% | 232,291 | 34.44K |
| 396 | COEP | Coeptis Therapeutics Holdings, Inc. | 68.58M | 5.96% | 16,913 | 1.36M |
| 397 | BYSI | BeyondSpring Inc. | 68.36M | 4.63% | 9,696 | 1.88M |
| 398 | ACET | Adicet Bio, Inc. | 65.16M | 1.49% | 27,566 | - |
| 399 | ANVS | Annovis Bio, Inc. | 64.93M | -3.38% | 349,313 | - |
| 400 | IBO | Impact BioMedical Inc. | 63.82M | -4.53% | 107,128 | 32.00K |
| 401 | ATHE | Alterity Therapeutics Limited | 62.53M | 3.60% | 312 | 4.43M |
| 402 | ACRV | Acrivon Therapeutics, Inc. | 61.60M | 0.63% | 363,720 | - |
| 403 | HYFT | MindWalk Holdings Corp. | 61.59M | 3.33% | 77,463 | 20.70M |
| 404 | EXOZ | eXoZymes, Inc. | 60.81M | - | 1,363 | -700.00 |
| 405 | TCRX | TScan Therapeutics, Inc. | 59.75M | 1.94% | 209,427 | 10.33M |
| 406 | IMA | ImageneBio, Inc. | 59.45M | 3.14% | 4,408 | 800.00K |
| 407 | TIL | Instil Bio, Inc. | 58.80M | 1.29% | 2,320 | - |
| 408 | ICCC | ImmuCell Corporation | 57.62M | 0.61% | 43 | 27.64M |
| 409 | MREO | Mereo BioPharma Group plc | 55.50M | 3.48% | 379,677 | 500.00K |
| 410 | OKUR | OnKure Therapeutics, Inc. | 54.83M | 0.75% | 58,484 | - |
| 411 | IMMP | Immutep Limited | 54.47M | 2.80% | 427,939 | 5.28M |
| 412 | LPCN | Lipocine Inc. | 54.02M | 0.54% | 45,526 | 1.98M |
| 413 | MGX | Metagenomi Therapeutics, Inc. | 53.80M | 4.38% | 81,539 | 25.21M |
| 414 | ENTX | Entera Bio Ltd. | 53.65M | 13.58% | 115,420 | 124.00K |
| 415 | EDSA | Edesa Biotech, Inc. | 53.60M | -8.55% | 271,403 | - |
| 416 | ATOS | Atossa Therapeutics, Inc. | 51.58M | 8.71% | 44,274 | - |
| 417 | ACTU | Actuate Therapeutics, Inc. | 50.90M | -0.90% | 38,247 | - |
| 418 | XLO | Xilio Therapeutics, Inc. | 48.92M | 1.08% | 11,609 | 43.77M |
| 419 | OSTX | OS Therapies Incorporated | 48.60M | - | 261,569 | - |
| 420 | RADX | Radiopharm Theranostics Limited | 48.44M | -0.97% | 130,252 | 10.86M |
| 421 | DCOY | Decoy Therapeutics Inc. | 46.89M | 1.10% | 5,165 | - |
| 422 | KZR | Kezar Life Sciences, Inc. | 46.58M | -0.78% | 4,768 | - |
| 423 | NTRB | Nutriband Inc. | 46.21M | 2.40% | 8,228 | 2.28M |
| 424 | LSTA | Lisata Therapeutics, Inc. | 45.34M | - | 9,771 | 170.00K |
| 425 | RLYB | Rallybio Corporation | 45.23M | -1.38% | 19,899 | 858.00K |
| 426 | GOVX | GeoVax Labs, Inc. | 44.84M | -3.12% | 25,073 | 3.35M |
| 427 | LITS | Lite Strategy, Inc. | 44.00M | 0.83% | 158,884 | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 43.49M | -1.17% | 20,871 | - |
| 429 | PSTV | Plus Therapeutics, Inc. | 43.25M | 5.09% | 1,534,942 | 5.21M |
| 430 | ATRA | Atara Biotherapeutics, Inc. | 42.36M | 3.81% | 32,284 | 120.77M |
| 431 | ALGS | Aligos Therapeutics, Inc. | 42.14M | 0.29% | 15,714 | 2.19M |
| 432 | INKT | MiNK Therapeutics, Inc. | 41.65M | 3.66% | 13,636 | - |
| 433 | RNXT | RenovoRx, Inc. | 40.68M | 2.78% | 231,029 | 928.00K |
| 434 | APLM | Apollomics, Inc. | 38.76M | 2.93% | 1,402 | 6.93M |
| 435 | ESLA | Estrella Immunopharma, Inc. | 38.52M | 4.63% | 45,839 | - |
| 436 | CRVO | CervoMed Inc. | 38.23M | 5.33% | 6,854 | 4.01M |
| 437 | NBY | NovaBay Pharmaceuticals, Inc. | 38.07M | -4.67% | 278,533 | 10.30M |
| 438 | HOWL | Werewolf Therapeutics, Inc. | 37.22M | -0.42% | 108,167 | 1.14M |
| 439 | VERU | Veru Inc. | 37.08M | 0.87% | 13,534 | 16.89M |
| 440 | SNSE | Sensei Biotherapeutics, Inc. | 36.90M | -2.40% | 33,417 | - |
| 441 | CELU | Celularity Inc. | 36.62M | - | 6,623 | 40.58M |
| 442 | LONA | LeonaBio, Inc. | 36.32M | 2.11% | 16,979 | - |
| 443 | PTN | Palatin Technologies, Inc. | 36.29M | 3.02% | 3,335 | 8.96M |
| 444 | NXTC | NextCure, Inc. | 35.85M | 1.31% | 34,211 | - |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 34.00M | 1.87% | 25,692 | 90.00K |
| 446 | RNTX | Rein Therapeutics Inc. | 33.38M | 4.10% | 10,883 | - |
| 447 | JSPR | Jasper Therapeutics, Inc. | 32.18M | - | 95,720 | - |
| 448 | INMB | INmune Bio Inc. | 32.17M | 2.54% | 105,419 | 50.00K |
| 449 | SER | Serina Therapeutics, Inc. | 31.99M | 23.46% | 1,689,164 | 116.00K |
| 450 | TVRD | Tvardi Therapeutics, Inc. | 31.71M | 0.60% | 8,475 | - |
| 451 | DYAI | Dyadic International, Inc. | 31.64M | 3.54% | 27,678 | 3.34M |
| 452 | TLSA | Tiziana Life Sciences Ltd | 31.37M | - | 31,557 | - |
| 453 | PLUR | Pluri Inc. | 30.76M | 0.33% | 945 | 1.34M |
| 454 | BCTX | BriaCell Therapeutics Corp. | 29.60M | 2.44% | 49,917 | - |
| 455 | HYPD | Hyperion DeFi, Inc. | 29.39M | 6.45% | 344,924 | 345.32K |
| 456 | PDSB | PDS Biotechnology Corporation | 29.39M | 9.07% | 338,246 | - |
| 457 | CVM | CEL-SCI Corporation | 28.93M | - | 21,422 | - |
| 458 | XCUR | Exicure, Inc. | 28.81M | 1.12% | 14,961 | 500.00K |
| 459 | ABVC | ABVC BioPharma, Inc. | 28.75M | - | 27,723 | 797.92K |
| 460 | CRIS | Curis, Inc. | 28.23M | -1.24% | 127,074 | 9.44M |
| 461 | KYNB | Kyntra Bio, Inc. | 27.90M | 2.15% | 2,576 | 6.44M |
| 462 | LTRN | Lantern Pharma Inc. | 26.34M | 5.61% | 7,862 | - |
| 463 | CUE | Cue Biopharma, Inc. | 25.68M | 3.14% | 367,893 | 27.47M |
| 464 | BOLD | Boundless Bio, Inc. | 25.54M | 0.88% | 22,859 | - |
| 465 | XTLB | XTL Biopharmaceuticals Ltd. | 25.34M | 10.07% | 44,705 | 968.00K |
| 466 | NRSN | NeuroSense Therapeutics Ltd. | 25.05M | 2.74% | 35,888 | - |
| 467 | IGC | IGC Pharma, Inc. | 24.89M | 5.93% | 224,458 | 1.11M |
| 468 | VTGN | Vistagen Therapeutics, Inc. | 24.87M | 1.85% | 314,342 | 789.00K |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 24.12M | -0.79% | 3,496 | 14.99M |
| 470 | SNTI | Senti Biosciences, Inc. | 23.75M | 4.86% | 55,279 | - |
| 471 | BRNS | Barinthus Biotherapeutics plc | 23.37M | 2.88% | 2,920 | 14.97M |
| 472 | PASG | Passage Bio, Inc. | 23.29M | 8.52% | 23,392 | - |
| 473 | TPST | Tempest Therapeutics, Inc. | 22.92M | -2.86% | 99,369 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 22.59M | 7.54% | 80,831 | 3.55M |
| 475 | LGVN | Longeveron Inc. | 21.06M | 1.29% | 209,164 | 1.20M |
| 476 | SKYE | Skye Bioscience, Inc. | 20.83M | -0.14% | 81,785 | - |
| 477 | VYNE | VYNE Therapeutics Inc. | 20.47M | 2.45% | 25,284 | 570.00K |
| 478 | NNVC | NanoViricides, Inc. | 20.33M | -0.93% | 155,938 | - |
| 479 | DARE | Daré Bioscience, Inc. | 19.86M | 2.21% | 11,007 | -57.13K |
| 480 | LEXX | Lexaria Bioscience Corp. | 19.45M | -0.06% | 39,961 | 522.00K |
| 481 | QNTM | Quantum BioPharma Ltd. | 18.16M | -0.42% | 963,851 | - |
| 482 | FBLG | FibroBiologics, Inc. | 17.98M | 3.38% | 223,378 | - |
| 483 | KTTA | Pasithea Therapeutics Corp. | 17.90M | 1.20% | 5,145 | - |
| 484 | ALLR | Allarity Therapeutics, Inc. | 17.71M | - | 35,402 | - |
| 485 | OTLK | Outlook Therapeutics, Inc. | 17.55M | 6.66% | 3,518,456 | 205.70K |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 16.19M | 1.91% | 81,773 | 3.94M |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 16.09M | 4.44% | 112,704 | - |
| 488 | TRAW | Traws Pharma, Inc. | 15.90M | -7.44% | 57,855 | 2.85M |
| 489 | INAB | IN8bio, Inc. | 15.41M | 0.97% | 97,274 | - |
| 490 | INTS | Intensity Therapeutics, Inc. | 15.19M | 1.27% | 9,133 | - |
| 491 | COCP | Cocrystal Pharma, Inc. | 14.82M | 1.42% | 15,536 | - |
| 492 | GNTA | Genenta Science S.p.A. | 14.70M | 6.65% | 63,931 | - |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.70M | 3.69% | 103,676 | - |
| 494 | GTBP | GT Biopharma, Inc. | 14.45M | -3.60% | 275,388 | - |
| 495 | IOBT | IO Biotech, Inc. | 14.39M | 4.71% | 349,171 | - |
| 496 | PLRZ | Polyrizon Ltd. | 13.99M | 5.12% | 10,742 | - |
| 497 | AEON | AEON Biopharma, Inc. | 13.94M | -4.72% | 104,049 | - |
| 498 | HOTH | Hoth Therapeutics, Inc. | 13.81M | 0.42% | 56,089 | - |
| 499 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.27M | 2.63% | 3,768,330 | - |
| 500 | BCDA | BioCardia, Inc. | 13.24M | 0.41% | 30,394 | 3.00K |